Print

Science Committee

IGBA (formerly IGPA) was initially founded to be able to participate as an Interested Party at the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). This forum brings together the regulatory authorities and the pharmaceutical industries of the European Union, Japan and the USA to discuss scientific and technical aspects of drug registration and develop scientific guidelines. The aim is to achieve greater harmonization and convergence between the various regions so that  high quality, safe and efficacious medicines can be developed and registered in the most resource-efficient manner. The IGBA Science Committee’s main activity rotates consequently around the bi-annual ICH meetings. It nominates experts from the generic medicines industry to those Expert Working Groups (EWGs) which are relevant for our industry sector.

Industry experts also participate on an ad-hoc basis in the following WHO activities, programmes and issues:

  • Prequalification Programme
  • Specification for pharmaceutical preparations
  • Paediatrics guideline
  • Essential medicines list
  • Generics guideline
  • INN Programme
  • Biological Standardizations
  • Similar biotherapeutics guideline

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

Rue d'Arlon, 50
B-1000 Brussels, Belgium

Telephone: +32 (0)2 736 84 11
Fax: +32 (0)2 736 74 38
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.